![Alexis Peyroles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexis Peyroles
Keine laufenden Positionen mehr
Vermögen: 2 Mio $ am 31.05.2026
Profil
Alexis Peyroles is the founder of Inside Therapeutics SAS, serving as Chairman & Chief Financial Officer since 2022.
Current jobs include Chief Executive Officer at Ose Immunotherapeutics, Inc., Chief Executive Officer & Director at Betaglue Technologies SpA starting in 2025, and Chairman at Aperana Consulting SAS. Former jobs include Chief Executive Officer & Director at OSE Immunotherapeutics SA from 2018 to 2022, Chief Executive Officer at Guerbet Imagem do Brasil Ltda., Manager-Financial Control at Guerbet SA, Head-Financial Control-Baltic States at Sanofi-Aventis Japan, Head-Eastern Europe Business Development at Sanofi-Aventis France SA, and CFO & Head-Business Development at Orphan Synergy Europe-Pharma SA. Education includes an undergraduate degree from École des Hautes Études Commerciales du Nord and an MBA from Imperial College Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2025 | 293.848 ( 1,3 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Alexis Peyroles
| Unternehmen | Position | Beginn |
|---|---|---|
Aperana Consulting SAS | Vorsitzender | - |
Ose Immunotherapeutics, Inc. | Vorstandsvorsitzender | - |
Betaglue Technologies SpA
 Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Provides medical technology research and oncology research services | Vorstandsvorsitzender | 22.09.2025 |
Ehemalige bekannte Positionen von Alexis Peyroles
| Unternehmen | Position | Ende |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Vorstandsvorsitzender | 16.01.2022 |
Guerbet Imagem do Brasil Ltda. | Vorstandsvorsitzender | - |
Sanofi-Aventis Japan | Comptroller/Controller/Auditor | - |
| GUERBET | Comptroller/Controller/Auditor | - |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Alexis Peyroles
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Guerbet SA
 Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products | Health Technology |
Sanofi-Aventis Japan | |
École des Hautes Études Commerciales du Nord
 École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Imperial College Business School
 Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aperana Consulting SAS | |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Betaglue Technologies SpA
Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Provides medical technology research and oncology research services | Commercial Services |
Ose Immunotherapeutics, Inc. | |
Guerbet Imagem do Brasil Ltda. |
